Top

Published in:

01-10-2021 | Antipsychotics | Narrative Review

Delirium in critical illness: clinical manifestations, outcomes, and management

Authors: Joanna L. Stollings, Katarzyna Kotfis, Gerald Chanques, Brenda T. Pun, Pratik P. Pandharipande, E. Wesley Ely

Published in: Intensive Care Medicine | Issue 10/2021

Abstract

Delirium is the most common manifestation of brain dysfunction in critically ill patients. In the intensive care unit (ICU), duration of delirium is independently predictive of excess death, length of stay, cost of care, and acquired dementia. There are numerous neurotransmitter/functional and/or injury-causing hypotheses rather than a unifying mechanism for delirium. Without using a validated delirium instrument, delirium can be misdiagnosed (under, but also overdiagnosed and trivialized), supporting the recommendation to use a monitoring instrument routinely. The best-validated ICU bedside instruments are CAM-ICU and ICDSC, both of which also detect subsyndromal delirium. Both tools have some inherent limitations in the neurologically injured patients, yet still provide valuable information about delirium once the sequelae of the primary injury settle into a new post-injury baseline. Now it is known that antipsychotics and other psychoactive medications do not reliably improve brain function in critically ill delirious patients. ICU teams should systematically screen for predisposing and precipitating factors. These include exacerbations of cardiac/respiratory failure or sepsis, metabolic disturbances (hypoglycemia, dysnatremia, uremia and ammonemia) receipt of psychoactive medications, and sensory deprivation through prolonged immobilization, uncorrected vision and hearing deficits, poor sleep hygiene, and isolation from loved ones so common during COVID-19 pandemic. The ABCDEF (A2F) bundle is a means to facilitate implementation of the 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS) Guidelines. In over 25,000 patients across nearly 100 institutions, the A2F bundle has been shown in a dose–response fashion (i.e., greater bundle compliance) to yield improved survival, length of stay, coma and delirium duration, cost, and less ICU bounce-backs and discharge to nursing homes.

Morandi A, Piva S, Ely EW, Myatra SN, Salluh JIF, Amare D, Azoulay E, Bellelli G, Csomos A, Fan E et al (2017) Worldwide survey of the “assessing pain, both spontaneous awakening and breathing trials, choice of drugs, delirium monitoring/management, early exercise/mobility, and family empowerment” (ABCDEF) bundle. Crit Care Med 45(11):e1111–e1122PubMedPubMedCentralCrossRef

Girard TD, Thompson JL, Pandharipande PP, Brummel NE, Jackson JC, Patel MB, Hughes CG, Chandrasekhar R, Pun BT, Boehm LM et al (2018) Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. Lancet Respir Med 6(3):213–222PubMedPubMedCentralCrossRef

Chanques G, Ely EW, Garnier O, Perrigault F, Eloi A, Carr J, Rowan CM, Prades A, de Jong A, Moritz-Gasser S et al (2018) The 2014 updated version of the confusion assessment method for the intensive care unit compared to the 5th version of the diagnostic and statistical manual of mental disorders and other current methods used by intensivists. Ann Intensive Care 8(1):33PubMedPubMedCentralCrossRef

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric AssociationCrossRef

Slooter AJC, Otte WM, Devlin JW, Arora RC, Bleck TP, Claassen J, Duprey MS, Ely EW, Kaplan PW, Latronico N et al (2020) Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive Care Med 46(5):1020–1022PubMedPubMedCentralCrossRef

Brummel NE, Boehm LM, Girard TD, Pandharipande PP, Jackson JC, Hughes CG, Patel MB, Han JH, Vasilevskis EE, Thompson JL et al (2017) Subsyndromal delirium and institutionalization among patients with critical illness. Am J Crit Care 26(6):447–455PubMedPubMedCentralCrossRef

Ouimet S, Riker R, Bergeron N, Cossette M, Kavanagh B, Skrobik Y (2007) Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 33(6):1007–1013PubMedCrossRef

Wood E, Albarqouni L, Tkachuk S, Green CJ, Ahamad K, Nolan S, McLean M, Klimas J (2018) Will this hospitalized patient develop severe alcohol withdrawal syndrome?: The rational clinical examination systematic review. JAMA 320(8):825–833PubMedPubMedCentralCrossRef

Salomon C, Hamilton B, Elsom S (2014) Experiencing antipsychotic discontinuation: results from a survey of Australian consumers. J Psychiatr Ment Health Nurs 21(10):917–923PubMedCrossRef

10.

Sivanesan E, Gitlin MC, Candiotti KA (2016) Opioid-induced hallucinations: a review of the literature, pathophysiology, diagnosis, and treatment. Anesth Analg 123(4):836–843PubMedPubMedCentralCrossRef

11.

Babkoff H, Sing HC, Thorne DR, Genser SG, Hegge FW (1989) Perceptual distortions and hallucinations reported during the course of sleep deprivation. Percept Mot Skills 68(3 Pt 1):787–798PubMedCrossRef

12.

Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R et al (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286(21):2703–2710PubMedCrossRef

13.

Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA et al (2008) Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 371(9607):126–134PubMedCrossRef

14.

Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291(14):1753–1762PubMedCrossRef

15.

Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y (2001) Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27(5):859–864PubMedCrossRef

16.

Guenther U, Popp J, Koecher L, Muders T, Wrigge H, Ely EW, Putensen C (2010) Validity and reliability of the CAM-ICU Flowsheet to diagnose delirium in surgical ICU patients. J Crit Care 25(1):144–151PubMedCrossRef

17.

Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, Douglas IS, Malhotra A, Owens RL, Feinstein DJ et al (2018) Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 379(26):2506–2516PubMedPubMedCentralCrossRef

18.

Salluh JI, Wang H, Schneider EB, Nagaraja N, Yenokyan G, Damluji A, Serafim RB, Stevens RD (2015) Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 350:2538CrossRef

19.

Peterson JF, Pun BT, Dittus RS, Thomason JW, Jackson JC, Shintani AK, Ely EW (2006) Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 54(3):479–484PubMedCrossRef

20.

Pandharipande P, Cotton BA, Shintani A, Thompson J, Costabile S, Truman Pun B, Dittus R, Ely EW (2007) Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 33(10):1726–1731PubMedCrossRef

21.

Hayhurst CJ, Marra A, Han JH, Patel MB, Brummel NE, Thompson JL, Jackson JC, Chandrasekhar R, Ely EW, Pandharipande PP et al (2020) Association of hypoactive and hyperactive delirium with cognitive function after critical illness. Crit Care Med 48(6):e480–e488PubMedPubMedCentralCrossRef

22.

Patel SB, Poston JT, Pohlman A, Hall JB, Kress JP (2014) Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med 189(6):658–665PubMedCrossRef

23.

Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK et al (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369(14):1306–1316PubMedPubMedCentralCrossRef

24.

Hughes CG, Boncyk CS, Culley DJ, Fleisher LA, Leung JM, McDonagh DL, Gan TJ, McEvoy MD, Miller TE (2020) Perioperative quality initiative w: american society for enhanced recovery and perioperative quality initiative joint consensus statement on postoperative delirium prevention. Anesth Analg 130(6):1572PubMedPubMedCentralCrossRef

25.

Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41(1):263–306PubMedCrossRef

26.

Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46(9):e825–e873PubMedCrossRef

27.

Han JH, Wilson A, Shintani AK, Graves AJ, Schnelle J, Vernon J, Dittus RS, Storrow AB, Ely EW (2011) The validation of the brief confusion assessment method in older emergency department patients. Ann Emerg Med 60(Suppl):S28

28.

Smith HA, Gangopadhyay M, Goben CM, Jacobowski NL, Chestnut MH, Savage S, Rutherford MT, Denton D, Thompson JL, Chandrasekhar R et al (2016) The preschool confusion assessment method for the ICU: valid and reliable delirium monitoring for critically Ill infants and children. Crit Care Med 44(3):592–600PubMedPubMedCentralCrossRef

29.

Smith HA, Boyd J, Fuchs DC, Melvin K, Berry P, Shintani A, Eden SK, Terrell MK, Boswell T, Wolfram K et al (2011) Diagnosing delirium in critically ill children: validity and reliability of the pediatric confusion assessment method for the intensive care unit. Crit Care Med 39(1):150–157PubMedPubMedCentralCrossRef

30.

Pun B, Devlin J (2013) Delirium monitoring in the ICU: strategies for initiating and sustaining screening efforts. Semin Respir Crit Care Med 34(02):179–188PubMedCrossRef

31.

Gusmao-Flores D, Salluh JI, Chalhub RA, Quarantini LC (2012) The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit Care 16(4):R115PubMedPubMedCentralCrossRef

32.

van Eijk MM, van den Boogaard M, van Marum RJ, Benner P, Eikelenboom P, Honing ML, van der Hoven B, Horn J, Izaks GJ, Kalf A et al (2011) Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med 184(3):340–344PubMedCrossRef

33.

Trzepacz PT (1999) The delirium rating scale - its use in consultation-liaison research. Psychosomatics 40(3):193–204PubMedCrossRef

34.

Inouye SK, Kosar CM, Tommet D, Schmitt EM, Puelle MR, Saczynski JS, Marcantonio ER, Jones RN (2014) The CAM-S: development and validation of a new scoring system for delirium severity in 2 cohorts. Ann Intern Med 160(8):526–533PubMedPubMedCentralCrossRef

35.

Khan BA, Perkins AJ, Gao S, Hui SL, Campbell NL, Farber MO, Chlan LL, Boustani MA (2017) The confusion assessment method for the ICU-7 delirium severity scale: a novel delirium severity instrument for use in the ICU. Crit Care Med 45(5):851–857PubMedPubMedCentralCrossRef

36.

Green C, Bonavia W, Toh C, Tiruvoipati R (2018) Prediction of ICU delirium: validation of current delirium predictive models in routine clinical practice. Crit Care Med 47(3):428–435CrossRef

37.

Soiza RL, Sharma V, Ferguson K, Shenkin SD, Seymour DG, Maclullich AM (2008) Neuroimaging studies of delirium: a systematic review. J Psychosom Res 65(3):239–248PubMedCrossRef

38.

Gunther ML, Morandi A, Krauskopf E, Pandharipande P, Girard TD, Jackson JC, Thompson J, Shintani AK, Geevarghese S, Miller RR 3rd et al (2012) The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study*. Crit Care Med 40(7):2022–2032PubMedPubMedCentralCrossRef

39.

Shioiri A, Kurumaji A, Takeuchi T, Matsuda H, Arai H, Nishikawa T (2010) White matter abnormalities as a risk factor for postoperative delirium revealed by diffusion tensor imaging. Am J Geriat Psyc 18(8):743–753CrossRef

40.

Morandi A, Gunther ML, Vasilevskis EE, Girard TD, Hopkins RO, Jackson JC, Pandharipande P, Ely EW (2010) Neuroimaging in delirious intensive care unit patients: a preliminary case series report. Psychiatry (Edgmont) 7(9):28–33

41.

Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L (1984) Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 246(6 Pt 2):R994-999PubMed

42.

van der Kooi AW, Zaal IJ, Klijn FA, Koek HL, Meijer RC, Leijten FS, Slooter AJ (2015) Delirium detection using EEG: what and how to measure. Chest 147(1):94–101PubMedCrossRef

43.

Kimchi EY, Neelagiri A, Whitt W, Sagi AR, Ryan SL, Gadbois G, Groothuysen D, Westover MB (2019) Clinical EEG slowing correlates with delirium severity and predicts poor clinical outcomes. Neurology 93(13):e1260–e1271PubMedPubMedCentralCrossRef

44.

Gilmore EJ, Gaspard N, Choi HA, Cohen E, Burkart KM, Chong DH, Claassen J, Hirsch LJ (2015) Acute brain failure in severe sepsis: a prospective study in the medical intensive care unit utilizing continuous EEG monitoring. Intensive Care Med 41(4):686–694PubMedCrossRef

45.

Klein Klouwenberg PM, Zaal IJ, Spitoni C, Ong DS, van der Kooi AW, Bonten MJ, Slooter AJ, Cremer OL (2014) The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ 349:g6652PubMedPubMedCentralCrossRef

46.

Duprey MS, van den Boogaard M, van der Hoeven JG, Pickkers P, Briesacher BA, Saczynski JS, Griffith JL, Devlin JW (2020) Association between incident delirium and 28- and 90-day mortality in critically ill adults: a secondary analysis. Crit Care 24(1):161PubMedPubMedCentralCrossRef

47.

Rood PJT, van de Schoor F, van Tertholen K, Pickkers P, van den Boogaard M (2019) Differences in 90-day mortality of delirium subtypes in the intensive care unit: a retrospective cohort study. J Crit Care 53:120–124PubMedCrossRef

48.

Hughes CG, Patel MB, Jackson JC, Girard TD, Geevarghese SK, Norman BC, Thompson JL, Chandrasekhar R, Brummel NE, May AK et al (2017) Surgery and anesthesia exposure is not a risk factor for cognitive impairment after major noncardiac surgery and critical illness. Ann Surg 265(6):1126–1133PubMedCrossRef

49.

Pandharipande PP, Ely EW, Arora RC, Balas MC, Boustani MA, La Calle GH, Cunningham C, Devlin JW, Elefante J, Han JH et al (2017) The intensive care delirium research agenda: a multinational, interprofessional perspective. Intensive Care Med 43(9):1329–1339PubMedPubMedCentralCrossRef

50.

Vasilevskis EE, Chandrasekhar R, Holtze CH, Graves J, Speroff T, Girard TD, Patel MB, Hughes CG, Cao A, Pandharipande PP et al (2018) The cost of ICU delirium and coma in the intensive care unit patient. Med Care 56(10):890–897PubMedPubMedCentralCrossRef

51.

Leslie DL, Inouye SK (2011) The importance of delirium: economic and societal costs. J Am Geriatr Soc 59(Suppl 2):S241-243PubMedPubMedCentralCrossRef

52.

Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, Jackson J, Perkins GD, McAuley DF (2013) Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 1(7):515–523PubMedPubMedCentralCrossRef

53.

van den Boogaard M, Slooter AJC, Bruggemann RJM, Schoonhoven L, Beishuizen A, Vermeijden JW, Pretorius D, de Koning J, Simons KS, Dennesen PJW et al (2018) Effect of haloperidol on survival among critically Ill adults with a high risk of delirium: the REDUCE randomized clinical trial. JAMA 319(7):680–690PubMedPubMedCentralCrossRef

54.

Prakanrattana U, Prapaitrakool S (2007) Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 35(5):714–719PubMedCrossRef

55.

Su X, Meng ZT, Wu XH, Cui F, Li HL, Wang DX, Zhu X, Zhu SN, Maze M, Ma D (2016) Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet 388(10054):1893–1902PubMedCrossRef

56.

Skrobik Y, Duprey MS, Hill NS, Devlin JW (2018) Low-dose nocturnal dexmedetomidine prevents ICU delirium a randomized, placebo-controlled trial. Am J Respir Crit Care Med 197(9):1147–1156PubMedCrossRef

57.

Morandi A, Hughes CG, Girard TD, McAuley DF, Ely EW, Pandharipande PP (2011) Statins and brain dysfunction a hypothesis to reduce the burden of cognitive impairment in patients who are critically III. Chest 140(3):580–585PubMedPubMedCentralCrossRef

58.

Mather JF, Corradi JP, Waszynski C, Noyes A, Duan Y, Grady J, Dicks R (2017) Statin and its association with delirium in the medical ICU. Crit Care Med 45(9):1515–1522PubMedCrossRef

59.

Billings FTT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ (2016) High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA 315(9):877–888PubMedPubMedCentralCrossRef

60.

Avidan MS, Maybrier HR, Abdallah AB, Jacobsohn E, Vlisides PE, Pryor KO, Veselis RA, Grocott HP, Emmert DA, Rogers EM et al (2017) Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet 390(10091):267–275PubMedPubMedCentralCrossRef

61.

Perbet S, Verdonk F, Godet T, Jabaudon M, Chartier C, Cayot S, Guerin R, Morand D, Bazin JE, Futier E et al (2018) Low doses of ketamine reduce delirium but not opiate consumption in mechanically ventilated and sedated ICU patients: a randomised double-blind control trial. Anaesth Crit Care Pain Med 37(6):589–595PubMedCrossRef

62.

Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY et al (2010) Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 38(2):428–437PubMedPubMedCentralCrossRef

63.

Collet MO, Caballero J, Sonneville R, Bozza FA, Nydahl P, Schandl A, Woien H, Citerio G, van den Boogaard M, Hastbacka J et al (2018) Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med 44(7):1081–1089PubMedCrossRef

64.

Page VJ, Casarin A, Ely EW, Zhao XB, McDowell C, Murphy L, McAuley DF (2017) Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 5(9):727–737PubMedCrossRef

65.

Reade MC, Eastwood GM, Bellomo R, Bailey M, Bersten A, Cheung B, Davies A, Delaney A, Ghosh A, van Haren F et al (2016) Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA 315(14):1460–1468PubMedCrossRef

66.

Louis C, Godet T, Chanques G, Bourguignon N, Morand D, Pereira B, Constantin JM (2018) network A: effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial. Trials 19(1):307PubMedPubMedCentralCrossRef

67.

Ono H, Taguchi T, Kido Y, Fujino Y, Doki Y (2011) The usefulness of bright light therapy for patients after oesophagectomy. Intensive Crit Care Nurs 27(3):158–166PubMedCrossRef

68.

Taguchi T, Yano M, Kido Y (2007) Influence of bright light therapy on postoperative patients: a pilot study. Intensive Crit Care Nurs 23(5):289–297PubMedCrossRef

69.

Simons KS, Laheij RJ, van den Boogaard M, Moviat MA, Paling AJ, Polderman FN, Rozendaal FW, Salet GA, van der Hoeven JG, Pickkers P et al (2016) Dynamic light application therapy to reduce the incidence and duration of delirium in intensive-care patients: a randomised controlled trial. Lancet Respir Med 4(3):194–202PubMedCrossRef

70.

Foster J, Kelly M (2013) A pilot study to test the feasibility of a nonpharmacologic intervention for the prevention of delirium in the medical intensive care unit. Clin Nurse Spec 27(5):231–238PubMedCrossRef

71.

Moon KJ, Lee SM (2015) The effects of a tailored intensive care unit delirium prevention protocol: a randomized controlled trial. Int J Nurs Stud 52(9):1423–1432PubMedCrossRef

72.

Colombo R, Corona A, Praga F, Minari C, Giannotti C, Castelli A, Raimondi F (2012) A reorientation strategy for reducing delirium in the critically ill. Results of an interventional study. Minerva Anestesiol 78(9):1026–1033PubMed

73.

Hanison J, Conway D (2015) A multifaceted approach to prevention of delirium on intensive care. BMJ Qual Improv Rep 4(1).

74.

Rivosecchi RM, Kane-Gill SL, Svec S, Campbell S, Smithburger PL (2016) The implementation of a nonpharmacologic protocol to prevent intensive care delirium. J Crit Care 31(1):206–211PubMedCrossRef

75.

Davidson JE, Aslakson RA, Long AC, Puntillo KA, Kross EK, Hart J, Cox CE, Wunsch H, Wickline MA, Nunnally ME et al (2017) Guidelines for family-centered care in the neonatal, pediatric, and adult ICU. Crit Care Med 45(1):103–128PubMedCrossRef

76.

Barnes-Daly MA, Phillips G, Ely EW (2017) Improving hospital survival and reducing brain dysfunction at seven california community hospitals: implementing PAD guidelines via the ABCDEF bundle in 6064 patients. Crit Care Med 45(2):171–178PubMedCrossRef

77.

Pun BT, Balas MC, Barnes-Daly MA, Thompson JL, Aldrich JM, Barr J, Byrum D, Carson SS, Devlin JW, Engel HJ et al (2019) Caring for critically Ill patients with the ABCDEF BUNDLE: results of the ICU liberation collaborative in over 15,000 adults. Crit Care Med 47(1):3–14PubMedPubMedCentralCrossRef

78.

Stollings JL, Devlin JW, Pun BT, Puntillo KA, Kelly T, Hargett KD, Morse A, Esbrook CL, Engel HJ, Perme C et al (2019) Implementing the ABCDEF bundle: top 8 questions asked during the ICU liberation ABCDEF bundle improvement collaborative. Crit Care Nurse 39(1):36–45PubMedCrossRef

79.

Balas MC, Pun BT, Pasero C, Engel HJ, Perme C, Esbrook CL, Kelly T, Hargett KD, Posa PJ, Barr J et al (2019) Common challenges to effective ABCDEF bundle implementation: the ICU liberation campaign experience. Crit Care Nurse 39(1):46–60PubMedCrossRef

80.

Hsieh SJ, Otusanya O, Gershengorn HB, Hope AA, Dayton C, Levi D, Garcia M, Prince D, Mills M, Fein D et al (2019) Staged implementation of awakening and breathing, coordination, delirium monitoring and management, and early mobilization bundle improves patient outcomes and reduces hospital costs. Crit Care Med 47(7):885–893PubMedPubMedCentralCrossRef

81.

Bannon L, McGaughey J, Verghis R, Clarke M, McAuley DF, Blackwood B (2019) The effectiveness of non-pharmacological interventions in reducing the incidence and duration of delirium in critically ill patients: a systematic review and meta-analysis. Intensive Care Med 45(1):1–12PubMedCrossRef

82.

Duprey MS, Dijkstra-Kersten SMA, Zaal IJ, Briesacher BA, Saczynski JS, Griffith JL, Devlin JW, Slooter AJC (2021) Opioid use increases the risk of delirium in critically ill adults independently of pain. Am J Respir Crit Care Med.

83.

Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM et al (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30(1):119–141PubMedCrossRef

84.

Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr, Dittus R, Ely EW (2008) Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 65(1):34–41PubMedPubMedCentral

85.

Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104(1):21–26PubMedCrossRef

86.

Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA et al (2007) Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 298(22):2644–2653PubMedCrossRef

87.

Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW et al (2009) Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301(5):489–499PubMedCrossRef

88.

Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J (2012) Dexmedetomidine for long-term sedation I: dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307(11):1151–1160PubMedCrossRef

89.

Carson SS, Kress JP, Rodgers JE, Vinayak A, Campbell-Bright S, Levitt J, Bourdet S, Ivanova A, Henderson AG, Pohlman A et al (2006) A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 34(5):1326–1332PubMedCrossRef

90.

Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, Bin Kadiman S, McArthur CJ, Murray L, Reade MC et al (2019) Early sedation with dexmedetomidine in critically Ill patients. N Engl J Med 380(26):2506–2517PubMedCrossRef

91.

Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, Jackson JC, Hoskins AS, Pun BT, Orun OM et al (2021) Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med 384(15):1424–1436PubMedCrossRefPubMedCentral

92.

Chanques G, Conseil M, Roger C, Constantin JM, Prades A, Carr J, Muller L, Jung B, Belafia F, Cisse M et al (2017) Immediate interruption of sedation compared with usual sedation care in critically ill postoperative patients (SOS-Ventilation): a randomised, parallel-group clinical trial. Lancet Respir Med 5(10):795–805PubMedCrossRef

93.

Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW (2020) COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care 24(1):176PubMedPubMedCentralCrossRef

94.

Pun BT, Badenes R, Heras La Calle G, Orun OM, Chen W, Raman R, Simpson BK, Wilson-Linville S, Hinojal OB, Vallejo de la Cueva A et al (2021) Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D) a multicentre cohort study. Lancet Respir Med 9(3):239–250PubMedPubMedCentralCrossRef

95.

Chanques G, Constantin JM, Devlin JW, Ely EW, Fraser GL, Gelinas C, Girard TD, Guerin C, Jabaudon M, Jaber S et al (2020) Analgesia and sedation in patients with ARDS. Intensive Care Med 46(12):2342–2356PubMedCrossRefPubMedCentral

Title: Delirium in critical illness: clinical manifestations, outcomes, and management
Authors: Joanna L. Stollings
Katarzyna Kotfis
Gerald Chanques
Brenda T. Pun
Pratik P. Pandharipande
E. Wesley Ely
Publication date: 01-10-2021
Publisher: Springer Berlin Heidelberg
Keywords: Antipsychotics
Care
Coma
Antipsychotics
Haloperidol
Published in: Intensive Care Medicine / Issue 10/2021
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-021-06503-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Delirium in critical illness: clinical manifestations, outcomes, and management

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2021

Could I see your soul?

Idiopathic paroxysmal atrioventricular block

“L’histoire se répète”, one size does not fit all

What’s new in mechanical support strategies for the intensivist in children with severe cardiac failure

Critical illness in patients with hematologic malignancy: a population-based cohort study

Time outside for a long-term ventilated ICU patient